189 Avsnitt

  1. BRCA Testing and Adjuvant Therapy in Early Breast Cancer: Experiences and Challenges

    Publicerades: 2023-04-05

  2. Experts Discuss Claudin 18.2: A New Target for Precision Care of Gastric and Gastroesophageal Cancers

    Publicerades: 2023-03-28

  3. Treatment Considerations for Patients With Essential Thrombocythemia: A Conversation Between Experts

    Publicerades: 2023-02-23

  4. FAQs on the Use of Asparaginase Therapy in Young and Older Adults With Acute Lymphoblastic Leukemia

    Publicerades: 2023-02-20

  5. Experts Answer Questions on the Management of Patients With T-Cell Lymphomas

    Publicerades: 2023-02-17

  6. Experts Answer Questions on Personalized Management of Patients With Myelodysplastic Syndromes

    Publicerades: 2023-02-17

  7. Individualizing Care for Patients With Triple-Negative Breast Cancer

    Publicerades: 2023-01-18

  8. Contemporary Approaches to Treating Polycythemia Vera: A Conversation Between Experts

    Publicerades: 2023-01-11

  9. HCC Surveillance: Challenges and Opportunities

    Publicerades: 2023-01-03

  10. A Patient’s Perspective on Effective Communication With the Healthcare Team: My Journey With High-Risk HR-Positive/HER2-Negative Early Breast Cancer

    Publicerades: 2022-12-13

  11. Expert Thoughts on Studies of Interest Presented at the 2022 ESGO Annual Meeting on Gynecologic Cancers

    Publicerades: 2022-11-29

  12. The Transgender Cancer Experience: A Conversation Between an Oncologist and a Transmasculine Individual on Navigating the Healthcare System

    Publicerades: 2022-11-29

  13. Evolving Role of BTK Inhibitors in CLL: Experts Answer Your Questions

    Publicerades: 2022-11-09

  14. New Evidence With BTK Inhibitor Therapy in CLL and MCL From the SOHO 2022 Annual Meeting

    Publicerades: 2022-10-28

  15. Expert Thoughts on Key Trials of Interest for Ovarian and Cervical Cancer at the IGCS 2022 Annual Global Meeting

    Publicerades: 2022-10-24

  16. Relapsed/Refractory Myeloma: Navigating the Complex Treatment Landscape

    Publicerades: 2022-10-24

  17. Expert Insights on Key Updates From the 2022 ESMO Congress on PARP Inhibitors in Ovarian Cancer

    Publicerades: 2022-10-04

  18. Managing EGFR-Mutated Non-Small-Cell Lung Cancer in Today’s Clinic: Expert Answers to Frequently Asked Questions

    Publicerades: 2022-09-28

  19. New Evidence With BTK Inhibitor Therapy in CLL and MCL From the Pan Pacific Lymphoma Conference 2022

    Publicerades: 2022-08-30

  20. Experts Discuss Challenges in Advanced Hepatocellular Carcinoma Management

    Publicerades: 2022-08-22

3 / 10

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

Visit the podcast's native language site